YOUR    CHALLENGES OFFERINGS
NEWS & EVENTS KNOWLEDGE CENTER ABOUT US DIAGNOSTICS
speaker_profile_image_4f380d9bb746f975031c01e831bbbf532a4f0868_3463_MOD-2-120-120-center.jpg
Manager, Medical and Scientific Affairs, Hematology, Abbott Diagnostic

Abstract 

von Willebrand Disease (vWD) is one of the most common congenital bleeding disorders, affecting ~1%* of the world’s population. An accurate diagnosis can be very challenging due to the heterogeneity of the disorder and preanalytical variables that may affect the assays used in the diagnosis. Clinical laboratories may perform both screening and complex assays to measure different properties and activities of von Willebrand factor (vWF) to aid clinicians with diagnosis. However, these assays may be adversely affected by preanalytical variables and often have altered performance characteristics that may contribute to inadequate interpretation.

 

Learing Objectives

  • Define vWD and its history
  • Go over current classification of vWD and assays utilized
  • Review structure and function of vWF
  • Discuss methods/technologies for diagnosing vWD, assay limitations, and preanalytical variables influencing vWD testing and interpretation


Don't miss a future webinar. Sign up today to receive updates.

Register now for on demand

Please fill out the form below to view the on demand recording.